用于阻塞性气道疾病的三联吸入器：它们会有用吗？ - Suppr

Suppr

超能文献

Triple inhalers for obstructive airways disease: will they be useful?

作者信息

Barnes Peter J

出版信息

Expert Rev Respir Med. 2011 Jun;5(3):297-300. doi: 10.1586/ers.11.26.

DOI:10.1586/ers.11.26

PMID:21702649

Abstract

摘要

相似文献

Triple inhalers for obstructive airways disease: will they be useful?

Expert Rev Respir Med. 2011 Jun;5(3):297-300. doi: 10.1586/ers.11.26.

[Triple therapy in chronic obstructive pulmonary disease].

Arch Bronconeumol. 2010;46 Suppl 8:25-30. doi: 10.1016/S0300-2896(10)70064-8.

COPD drugs: the urgent need for innovation.

Lancet Respir Med. 2014 Jan;2(1):14-5. doi: 10.1016/S2213-2600(13)70278-9. Epub 2013 Dec 23.

[Triple fix-dose combination for treatment of COPD: convenient and effective].

Dtsch Med Wochenschr. 2016 Nov;141(23):1668. doi: 10.1055/s-0042-119060. Epub 2016 Nov 17.

M(2)-β(2) interaction: a basis for combined bronchodilator treatment.

Arch Bronconeumol. 2013 Jul;49(7):279-81. doi: 10.1016/j.arbres.2012.10.001. Epub 2012 Nov 1.

[Asthma and COPD: guidance in the jungle of inhalative drugs].

MMW Fortschr Med. 2015 May 28;157(10):59, 61-2. doi: 10.1007/s15006-015-3139-6.

Changes in inhaler devices for asthma and COPD.

Medsurg Nurs. 2005 Jun;14(3):185-94.

Ultra-LAMA, ultra-LABA, ultra-inhaled steroids? The future has landed.

Arch Bronconeumol. 2013 Apr;49(4):131-4. doi: 10.1016/j.arbres.2012.11.011. Epub 2013 Feb 15.

Seebri Neohaler and Utibron Neohaler for COPD.

Med Lett Drugs Ther. 2016 Mar 28;58(1491):39-41.

Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?

Expert Opin Pharmacother. 2011 Aug;12(12):1913-32. doi: 10.1517/14656566.2011.589837. Epub 2011 Jun 30.

引用本文的文献

Pharmacologic Activities of Plant-Derived Natural Products on Respiratory Diseases and Inflammations.

Biomed Res Int. 2021 Oct 4;2021:1636816. doi: 10.1155/2021/1636816. eCollection 2021.

Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap.

Int J Chron Obstruct Pulmon Dis. 2020 Feb 5;15:269-277. doi: 10.2147/COPD.S231004. eCollection 2020.

Effect of triple therapy in patients with asthma-COPD overlap .

Int J Clin Pharmacol Ther. 2019 Aug;57(8):384-392. doi: 10.5414/CP203382.

A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Int J Respir Pulm Med. 2018;5(2). doi: 10.23937/2378-3516/1410098. Epub 2018 Nov 29.

A review of nebulized drug delivery in COPD.

Int J Chron Obstruct Pulmon Dis. 2016 Oct 18;11:2585-2596. doi: 10.2147/COPD.S114034. eCollection 2016.

Crosstalk between beta-2-adrenoceptor and muscarinic acetylcholine receptors in the airway.

Curr Opin Pharmacol. 2014 Jun;16:72-81. doi: 10.1016/j.coph.2014.03.005. Epub 2014 Apr 17.

Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

J Microbiol. 2014 Mar;52(3):211-26. doi: 10.1007/s12275-014-4068-2. Epub 2014 Mar 1.

The pharmacological approach to the elderly COPD patient.

Drugs Aging. 2013 Jul;30(7):479-502. doi: 10.1007/s40266-013-0080-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Triple inhalers for obstructive airways disease: will they be useful?

Expert Rev Respir Med. 2011 Jun;5(3):297-300. doi: 10.1586/ers.11.26.

[Triple therapy in chronic obstructive pulmonary disease].

Arch Bronconeumol. 2010;46 Suppl 8:25-30. doi: 10.1016/S0300-2896(10)70064-8.

COPD drugs: the urgent need for innovation.

Lancet Respir Med. 2014 Jan;2(1):14-5. doi: 10.1016/S2213-2600(13)70278-9. Epub 2013 Dec 23.

[Triple fix-dose combination for treatment of COPD: convenient and effective].

Dtsch Med Wochenschr. 2016 Nov;141(23):1668. doi: 10.1055/s-0042-119060. Epub 2016 Nov 17.

M(2)-β(2) interaction: a basis for combined bronchodilator treatment.

Arch Bronconeumol. 2013 Jul;49(7):279-81. doi: 10.1016/j.arbres.2012.10.001. Epub 2012 Nov 1.

[Asthma and COPD: guidance in the jungle of inhalative drugs].

MMW Fortschr Med. 2015 May 28;157(10):59, 61-2. doi: 10.1007/s15006-015-3139-6.

Changes in inhaler devices for asthma and COPD.

Medsurg Nurs. 2005 Jun;14(3):185-94.

Ultra-LAMA, ultra-LABA, ultra-inhaled steroids? The future has landed.

Arch Bronconeumol. 2013 Apr;49(4):131-4. doi: 10.1016/j.arbres.2012.11.011. Epub 2013 Feb 15.

Seebri Neohaler and Utibron Neohaler for COPD.

Med Lett Drugs Ther. 2016 Mar 28;58(1491):39-41.

Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?

Expert Opin Pharmacother. 2011 Aug;12(12):1913-32. doi: 10.1517/14656566.2011.589837. Epub 2011 Jun 30.

引用本文的文献

Pharmacologic Activities of Plant-Derived Natural Products on Respiratory Diseases and Inflammations.

Biomed Res Int. 2021 Oct 4;2021:1636816. doi: 10.1155/2021/1636816. eCollection 2021.

Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap.

Int J Chron Obstruct Pulmon Dis. 2020 Feb 5;15:269-277. doi: 10.2147/COPD.S231004. eCollection 2020.

Effect of triple therapy in patients with asthma-COPD overlap .

Int J Clin Pharmacol Ther. 2019 Aug;57(8):384-392. doi: 10.5414/CP203382.

A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Int J Respir Pulm Med. 2018;5(2). doi: 10.23937/2378-3516/1410098. Epub 2018 Nov 29.

A review of nebulized drug delivery in COPD.

Int J Chron Obstruct Pulmon Dis. 2016 Oct 18;11:2585-2596. doi: 10.2147/COPD.S114034. eCollection 2016.

Crosstalk between beta-2-adrenoceptor and muscarinic acetylcholine receptors in the airway.

Curr Opin Pharmacol. 2014 Jun;16:72-81. doi: 10.1016/j.coph.2014.03.005. Epub 2014 Apr 17.

Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

J Microbiol. 2014 Mar;52(3):211-26. doi: 10.1007/s12275-014-4068-2. Epub 2014 Mar 1.

The pharmacological approach to the elderly COPD patient.

Drugs Aging. 2013 Jul;30(7):479-502. doi: 10.1007/s40266-013-0080-1.